Cancer Hallmarks and MicroRNAs: The Therapeutic Connection

Human cancers are characterized by a number of hallmarks, including sustained proliferative signaling, evasion of growth suppressors, activated invasion and metastasis, replicative immortality, angiogenesis, resistance to cell death, and evasion of immune destruction. As microRNAs (miRNAs) are dereg...

Full description

Saved in:
Bibliographic Details
Published inAdvances in cancer research Vol. 135; p. 119
Main Authors Van Roosbroeck, Katrien, Calin, George A
Format Journal Article
LanguageEnglish
Published United States 2017
Subjects
Animals
Humans
MicroRNAs - genetics
Neoplasms - genetics
Cancer hallmarks
Targeted therapy
Immunotherapy
MicroRNAs
Proliferation
Coding gene targets
Invasion
Online AccessGet full text
ISSN2162-5557
2162-5557
DOI10.1016/bs.acr.2017.06.002

Cover

More Information
Summary:Human cancers are characterized by a number of hallmarks, including sustained proliferative signaling, evasion of growth suppressors, activated invasion and metastasis, replicative immortality, angiogenesis, resistance to cell death, and evasion of immune destruction. As microRNAs (miRNAs) are deregulated in virtually all human cancers, they show involvement in each of the cancer hallmarks as well. In this chapter, we describe the involvement of miRNAs in cancer from a cancer hallmarks and targeted therapeutics point of view. As no miRNA-based cancer therapeutics are available to date, and the only clinical trial on miRNA-based cancer therapeutics (MRX34) was terminated prematurely due to serious adverse events, we are focusing on protein-coding miRNA targets for which targeted therapeutics in oncology are already approved by the FDA. For each of the cancer hallmarks, we selected major protein-coding players and describe the miRNAs that target them.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2162-5557
2162-5557
DOI:10.1016/bs.acr.2017.06.002